Cartesian Therapeutics, Inc. (RNAC) Earnings
NASDAQ·Healthcare·Biotechnology
$10.38
+14.64%
Mkt Cap $252.68M
EPS — Estimate vs Actual
Mkt Cap
$252.68M
P/E
—
Fwd P/E
—
P/S
64.45
Rev TTM
—
EPS TTM
-$5.02
NASDAQ·Healthcare·Biotechnology
$10.38
+14.64%
Mkt Cap $252.68M
Mkt Cap
$252.68M
P/E
—
Fwd P/E
—
P/S
64.45
Rev TTM
—
EPS TTM
-$5.02